Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience-Reference-Cited by-同舟云学术

Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience

Published:2020-05-24 Issue:5 Volume:11 Page:283-293
ISSN:2218-4333
Container-title:World Journal of Clinical Oncology
language:
Short-container-title:WJCO

Author:

Kee Ga-Jing,Tan Ryan Ying-Cong,Rehena Sultana,Lee Joycelyn Jie-Xin,Zaw Ma Wai-Wai,Lian Wei-Xiang,Yeong Joe,Tan Su-Ming,Lim Swee-Ho,Tan Benita Kiat-Tee,Yap Yoon-Sim,Dent Rebecca Alexandra,Wong Fuh-Yong,Lee Guek-Eng

Publisher

Baishideng Publishing Group Inc.

Subject

Oncology

Reference18 articles.

1. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

2. Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma

3. Changes in Breast Cancer Incidence Rates in the United States by Histologic Subtype and Race/Ethnicity, 1995 to 2004

4. Genomic Characterization of Primary Invasive Lobular Breast Cancer

5. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. İnvaziv lobüler meme karsinomunun klinik özellikleri ve sağkalim sonuçları;Turkish Journal of Clinics and Laboratory;2024-07-01

2. Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes;Breast Cancer Research and Treatment;2023-07-27

3. Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases;European Journal of Cancer;2023-05